Resmed (RMD) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)
Powered by 
Analysis
Resmed (RMD) Net Income towards Common Stockholders Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 22.97% |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 20.02% |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 51.47% |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | -7.83% |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 29.05% |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 18.63% |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | - |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn | 17.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.63% |
| Mar 31, 2026 | 19.70% |
| Dec 31, 2025 | 20.40% |
| Sep 30, 2025 | 18.31% |
| Jun 30, 2025 | 24.86% |
| Mar 31, 2025 | 26.81% |
| Dec 31, 2024 | 19.54% |
| Sep 30, 2024 | 15.21% |
| Jun 30, 2024 | 14.42% |
| Mar 31, 2024 | 79.97% |
| Dec 31, 2023 | 5.17% |
| Sep 30, 2023 | 7.15% |
| Jun 30, 2023 | 8.90% |
| Mar 31, 2023 | 12.54% |
| Dec 31, 2022 | 11.89% |
| Sep 30, 2022 | 20.55% |
| Jun 30, 2022 | 53.69% |
| Mar 31, 2022 | 19.30% |
| Dec 31, 2021 | 17.41% |
| Sep 30, 2021 | 24.41% |